Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Hospira is recalling 216,880 units of Hydromorphone Hydrochloride Injection because the prefilled cartridges were found to be overfilled, containing more than the labeled 1 mL volume.
Raritan Pharmaceuticals is recalling Premier Value Fiber Plus Calcium Supplement Capsules due to possible C. difficile contamination in raw materials.
Bristol-Myers Squibb is recalling 31,481 BiCNU kits nationwide and in Puerto Rico because stability testing revealed an overfilled vial in a single lot.
Raritan Pharmaceuticals is recalling Leader Fiber Capsules due to possible C. difficile contamination found in raw materials.
Watson Laboratories is recalling specific lots of Necon 10/11 oral contraceptives because they may contain trace amounts of Hydrochlorothiazide (HCTZ).
Raritan Pharmaceuticals is recalling Wal-Mucil Plus Calcium Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Premier Value Fiber Capsules due to possible C. difficile contamination found in the raw material.
Mylan Pharmaceuticals is recalling 24,331 bottles of Doxazosin Tablets, USP, 2 mg, due to cross-contamination with acetaminophen and codeine.
Watson Laboratories is recalling Necon 1/35-28 tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ). The recall covers 6,466 cartons distributed nationwide and in Puerto Rico.
Raritan Pharmaceuticals is recalling CVS Pharmacy Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Simply Right Healthcare Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Up&Up Psyllium Fiber Supplement due to possible C. difficile contamination in the raw material.
Raritan Pharmaceuticals is recalling DRxChoice Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Berkley & Jensen Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Best Choice Health Care Psyllium Fiber Supplement due to possible C. difficile contamination in raw materials.
Raritan Pharmaceuticals is recalling specific lots of Wal-Mucil fiber laxative capsules due to possible C. difficile contamination in the raw material.
Raritan Pharmaceuticals is recalling Equate Fiber Therapy capsules due to possible C. difficile contamination found in raw materials.
Watson Laboratories is recalling Zovia tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ) due to cross-contamination.
Watson Laboratories is recalling Zenchent tablets because certain lots may be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
Vintage Pharmaceuticals is recalling 2,755 bottles of Perphenazine 8 mg tablets due to a possibility of cracked or split tablet coatings.
Watson Laboratories is recalling specific lots of Lutera tablets because they may contain trace amounts of Hydrochlorothiazide (HCTZ).
Bristol-Myers Squibb is recalling specific lots of Kombiglyze XR physician sample cartons because the external packaging was incorrectly labeled as 2.5mg/1000mg, while the contents were 5mg/500mg.
Bristol-Myers Squibb is recalling 117,049 physician sample cartons of Kombiglyze XR because some external cartons were mislabeled with the wrong dosage, though the individual blister units inside are correctly labeled.
Earthborn Products is recalling 161 gallons of colloidal silver supplements because the FDA determined the product is misbranded and not generally recognized as safe and effective.
Sandoz Incorporated is recalling specific lots of Children's Cetirizine Hydrochloride Chewable Tablets because they exceeded impurity specifications.